NSCLC (NON-SMALL CELL LUNG CARCINOMA)
Clinical trials for NSCLC (NON-SMALL CELL LUNG CARCINOMA) explained in plain language.
Never miss a new study
Get alerted when new NSCLC (NON-SMALL CELL LUNG CARCINOMA) trials appear
Sign up with your email to follow new studies for NSCLC (NON-SMALL CELL LUNG CARCINOMA), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New approach targets lung Cancer's genetic engine
Disease control Recruiting nowThis early-stage trial is testing a new drug called BG-60366 in people with advanced non-small cell lung cancer that has a specific genetic change called an EGFR mutation. The drug is designed to find and break down the faulty protein that drives this type of cancer. Researchers …
Matched conditions: NSCLC (NON-SMALL CELL LUNG CARCINOMA)
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated Apr 01, 2026 20:10 UTC
-
New hope for tough lung cancers: targeted pill challenges chemo
Disease control Recruiting nowThis study is testing whether a new oral drug called daraxonrasib works better than standard chemotherapy (docetaxel) for people with advanced non-small cell lung cancer that has a specific genetic change (RAS mutation) and has stopped responding to initial treatments. About 420 …
Matched conditions: NSCLC (NON-SMALL CELL LUNG CARCINOMA)
Phase: PHASE3 • Sponsor: Revolution Medicines, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC